Potent systemic therapy of Multiple Myeloma utilizing Oncolytic Vesicular stomatitis virus coding for Interferon-beta

Potent systemic therapy of Multiple Myeloma utilizing Oncolytic Vesicular stomatitis virus coding for Interferon-beta

Multiple myeloma (MM) is an incurable malignancy of plasma secreting B-cells disseminated in the bone marrow. Successful utilization of oncolytic virotherapy for myeloma treatment requires a systemically administered virus that selectively destroys disseminated myeloma cells in an immune-competent h...

Full description

Bibliographic Details
Main Authors:	Naik, Shruthi, Nace, Rebecca, Barber, Glen N., Russell, Stephen J.
Format:	Online
Language:	English
Published:	2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380174/

Similar Items

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV
by: Yarde, Danielle N., et al.
Published: (2013)

Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer
by: Heiber, Joshua F., et al.
Published: (2011)

Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia
by: Betancourt, Dillon, et al.
Published: (2015)

Curative one-shot systemic virotherapy in murine myeloma
by: Naik, Shruthi, et al.
Published: (2012)

Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
by: Muik, Alexander, et al.
Published: (2012)

Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy
by: Simovic, Boris, et al.
Published: (2015)

Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity
by: Bourgeois-Daigneault, Marie-Claude, et al.
Published: (2016)

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer
by: Patel, Manish R., et al.
Published: (2015)

Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy
by: Miller, Amber, et al.
Published: (2014)

Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines
by: Bridle, Byram W, et al.
Published: (2013)

N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells
by: Corredor, Juan C, et al.
Published: (2016)

Experimental Evolution of an Oncolytic Vesicular Stomatitis Virus with Increased Selectivity for p53-Deficient Cells
by: Garijo, Raquel, et al.
Published: (2014)

Autophagy Gene Activity May Act As a Key Factor for Sensitivity of Tumor Cells to Oncolytic Vesicular Stomatitis Virus
by: Nabizadeh, Arezoo, et al.
Published: (2016)

Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein
Published: (1979)

EFFECT OF FORMALIN ON THE VIRUS OF VESICULAR STOMATITIS OF HORSES
by: Olitsky, Peter K., et al.
Published: (1928)

A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
by: Berger Rentsch, Marianne, et al.
Published: (2011)

MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy
by: Ruiz, Autumn J., et al.
Published: (2016)

Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters
by: Bailey, Kent, et al.
Published: (2013)

The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes
Published: (1981)

Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses
Published: (1981)

Transport of newly synthesized vesicular stomatitis viral glycoprotein to purified Golgi membranes
Published: (1981)

ELECTRON MICROSCOPIC STUDIES ON THE DEVELOPMENT OF VESICULAR STOMATITIS VIRUS IN KB CELLS
by: Mussgay, M., et al.
Published: (1963)

COMPARATIVE STUDIES ON THE VIRUSES OF VESICULAR STOMATITIS AND EQUINE ENCEPHALOMYELITIS (1)
by: Olitsky, Peter K., et al.
Published: (1934)

Structure of the Vesicular Stomatitis Virus N0-P Complex
by: Leyrat, Cédric, et al.
Published: (2011)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
by: Moeschler, Sarah, et al.
Published: (2016)

Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes
by: Logan, Nicola, et al.
Published: (2016)

Cellular microRNAs Repress Vesicular Stomatitis Virus but Not Theiler’s Virus Replication
by: De Cock, Aurélie, et al.
Published: (2016)

In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion
by: Wongthida, Phonphimon, et al.
Published: (2016)

Impact of Vesicular Stomatitis Virus M Proteins on Different Cellular Functions
by: Redondo, Natalia, et al.
Published: (2015)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
by: Marzi, Andrea, et al.
Published: (2015)

Cellular Proteins Associated with the Interior and Exterior of Vesicular Stomatitis Virus Virions
by: Moerdyk-Schauwecker, Megan, et al.
Published: (2014)

Genome Sequences of Nine Vesicular Stomatitis Virus Isolates from South America
by: Fowler, Veronica L., et al.
Published: (2016)

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy
by: Cerullo, Vincenzo, et al.
Published: (2012)

Oncolytic Virotherapy for Multiple Myeloma: Past, Present, and Future
by: Thirukkumaran, Chandini M., et al.
Published: (2011)

Interferon Regulatory Factor-1 Protects from Fatal Neurotropic Infection with Vesicular Stomatitis Virus by Specific Inhibition of Viral Replication in Neurons
by: Nair, Sharmila, et al.
Published: (2014)

A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth
by: Yoon, A-Rum, et al.
Published: (2015)

Targeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus
by: Kirn, David H, et al.
Published: (2007)

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses
Published: (1976)

Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
by: Xu, Haineng, et al.
Published: (2014)

ONCOLYTIC VIROTHERAPY
by: Russell, Stephen J, et al.
Published: (2012)